Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Quince Therapeutics Inc (QNCX)

  • Event
  • Aug. 25, 2022, 13:09 UTC
  • 95
  • 0 comments

Quince Therapeutics to Present at Upcoming Scientific Meetings

Comment Full text

Regeneron Pharmaceuticals Inc. (REGN)

  • Event
  • Aug. 25, 2022, 13:06 UTC
  • 94
  • 0 comments

Regeneron Announces Investor Conference Presentations

Comment Full text

Adaptimmune Therapeutics plc (ADAP)

  • Event
  • Aug. 25, 2022, 05:03 UTC
  • 98
  • 0 comments

<p>Adaptimmune to Host Live, Virtual Event to Review Phase 1 SURPASS Trial Data and Outline Plans for Further Development in SURPASS Family of Trials</p>

Comment Full text

Oyster Point Pharma Inc (OYST)

  • Event
  • Aug. 25, 2022, 05:02 UTC
  • 102
  • 0 comments

<p>Oyster Point Pharma to Present Analyses at the Women in Ophthalmology Summer Symposium</p>

Comment Full text

Horizon Therapeutics plc (HZNP)

  • Event
  • Aug. 25, 2022, 05:01 UTC
  • 98
  • 0 comments

<p>Horizon Therapeutics plc to Present at the Morgan Stanley 20th Annual Global Healthcare Conference</p>

Comment Full text

Clearside Biomedical Inc (CLSD)

  • Event
  • Aug. 25, 2022, 04:06 UTC
  • 96
  • 0 comments

<p>Clearside Biomedical to Present at the Ophthalmology Futures Retina Forum 2022</p>

Comment Full text

Immuneering Corporation (IMRX)

  • Event
  • Aug. 25, 2022, 03:52 UTC
  • 93
  • 0 comments

<p>Immuneering Announces Participation in September Investor Conferences</p>

Comment Full text

Reata Pharmaceuticals Inc. (RETA)

  • Event
  • Aug. 22, 2022, 14:01 UTC
  • 98
  • 0 comments

Reata Pharmaceuticals Inc. - Corporate Presentation

Comment Full text

Pfizer Inc. (PFE)

  • Event
  • Aug. 19, 2022, 07:02 UTC
  • 93
  • 0 comments

Pfizer Inc. - Handelsbanken Life Science Innovation Day 2022

Comment Full text

Evolus Inc. (EOLS)

  • Event
  • Aug. 17, 2022, 11:00 UTC
  • 98
  • 0 comments

Evolus - August 2022 Investor Presentation

Comment Full text
  • Previous
  • 120
  • 121
  • 122
  • 123
  • 124
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189146)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124505)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin